Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 10, 2021, GoodRx Holdings, Inc. (the "Company") held its Annual Meeting of Stockholders. Holders of the Company's Class A common stock were entitled to one vote per share held as of the close of business on April 16, 2021 (the "Record Date") and holders of the Company's Class B common stock were entitled to ten votes per share held as of the Record Date. A total of 50,176,842 shares of the Company's Class A common stock and 319,339,392 shares of the Company's Class B common stock were present in person or represented by proxy at the meeting, representing approximately 98.7% percent of the combined voting power of the Company's Class A and Class B common stock as of the Record Date. The following are the voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on April 27, 2021.

Item 1 - Election of three Class I directors for a term of office expiring on the date of the annual meeting of stockholders in 2024 and until their respective successors have been duly elected and qualified.





                                                      Votes            Broker
                                  Votes FOR          WITHHELD        Non-Votes
         Douglas Hirsch          3,210,479,849       10,527,893       22,563,022
         Jacqueline Kosecoff     3,206,240,166       14,767,576       22,563,022
         Agnes Rey-Giraud        3,211,753,474        9,254,268       22,563,022

Item 2 - Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021.





            Votes FOR     Votes AGAINST   Votes ABSTAINED   Broker Non-Votes
          3,243,088,795      264,511          217,458              0

Based on the foregoing votes, Douglas Hirsch, Jacqueline Kosecoff and Agnes Rey-Giraudwere elected and Item 2 was approved.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses